MedTrace Logo

Effects of Reiki and Self-Acupressure Applications

NCT07083856 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2025-07-24

No results posted yet for this study

Summary

Reiki, the subject of our research, is a complementary medicine practice within energy approaches. Discovered in Sanskrit texts by Dr. Usui in Japan in the late 19th century, it was demonstrated through studies demonstrating its effectiveness in symptoms of pain, depression, insomnia, and fatigue. Everything in the universe, including the human body, is composed of energy; any disruption in this energy can lead to illness. There are seven chakras where Reiki is applied. The main chakra centers are located along the spine. During Reiki treatments, the hands are held in each position, touching the head, neck, chest, abdominal cavity, and groin for 3-5 minutes. This period may extend to 10-20 minutes in problematic areas. The average treatment duration is 30-90 minutes. During the treatment, the patient lies down or reclines, and there is no need to remove clothing. During Reiki treatment, individuals may report a slight warming sensation under or near the therapist's hand. The only rule in Reiki practice is that the individual gives the practitioner permission to facilitate the flow of energy. The person receiving Reiki does not need to believe in Reiki during the treatment. Reiki is a universal life energy present in everyone. Reiki is generally safe, and no serious side effects have been reported. Over the last 10 years, Reiki practice has been increasing among physicians, nurses, and other healthcare professionals. This study will compare the effects of acupressure and Reiki treatments on functionality and quality of life in patients with multiple sclerosis.

Conditions

Interventions

BEHAVIORAL

Reiki

Reiki

BEHAVIORAL

Self-Acupressure

Self-Acupressure

Sponsors & Collaborators

  • Firat University

    lead OTHER

Principal Investigators

  • Caner F Demir, MD · Firat University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-04-20
Primary Completion
2025-07-20
Completion
2025-09-20

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07083856 on ClinicalTrials.gov